Prestige Consumer Healthcare Quarterly Cash Flow Statement
NYSE: PBHHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Prestige Consumer Healthcare free cash flow
In the quarter ended Jun 30, 2026, Prestige Consumer Healthcare generated $70.8 million of operating cash flow and spent $3.7 million on capital expenditures. That left free cash flow of $67.1 million, a free-cash-flow margin of 25.2% of revenue. Free cash flow was down 14.2% from the prior year's $78.2 million.
Summary generated from market data by MetaCap's automated system. Methodology
Prestige Consumer Healthcare cash flow statement (quarterly)
| Quarter (USD) | Q1 20272026-06-30 | Q4 20262026-03-31 | Q3 20262025-12-31 | Q2 20262025-09-30 | Q1 20262025-06-30 | Q4 20252025-03-31 | Q3 20252024-12-31 | Q2 20252024-09-30 | Q1 20252024-06-30 | Q4 20242024-03-31 | Q3 20242023-12-31 | Q2 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 29.18M | 53.93M | 46.70M | 42.21M | 47.47M | 50.13M | 61.03M | 54.38M | 49.07M | 49.46M | 53.05M | 53.56M |
| Net Income growth (YoY) | -38.53% | +7.58% | -23.49% | -22.37% | -3.26% | +1.35% | +15.05% | +1.53% | -7.90% | — | +2.11% | +4.97% |
| Depreciation & Amortization | 8.75M | 8.35M | 7.59M | 7.66M | 7.67M | 7.25M | 6.87M | 7.93M | 8.12M | 7.84M | 7.65M | 7.64M |
| Stock-Based Compensation | 3.99M | 2.65M | 2.74M | 1.77M | 3.68M | 2.73M | 2.87M | 2.13M | 3.42M | 3.73M | 2.45M | 3.69M |
| Change in Working Capital | 25.41M | -18.62M | 6.90M | -12.05M | 13.90M | -19.97M | -8.94M | 1.29M | -5.79M | -3.76M | 2.23M | -8.38M |
| Operating Cash Flow | 70.79M | 42.84M | 78.29M | 57.49M | 79.01M | 61.85M | 65.09M | 69.80M | 54.78M | 66.91M | 71.47M | 62.46M |
| Capital Expenditures | -3.70M | -5.21M | -3.03M | -2.10M | -838.00K | -3.48M | -1.57M | -2.03M | -1.15M | -3.14M | -2.00M | -2.93M |
| Investing Cash Flow | -1.06B | -3.41M | -128.56M | -2.93M | -1.94M | -3.48M | -9.82M | -2.03M | -2.13M | -15.00M | -4.50M | -2.93M |
| Share Repurchases | 0 | -690.00K | -45.82M | -75.00M | -34.77M | -11.31M | -2.40M | -11.82M | -25.98M | 0 | 0 | 0 |
| Debt Issued | 1.04B | — | — | — | 0 | — | — | — | — | — | — | — |
| Financing Cash Flow | 1.02B | -38.10M | -6.73M | -74.95M | -36.28M | -11.49M | -53.87M | -51.20M | -65.52M | -68.44M | -64.84M | -53.55M |
| Net Change in Cash | 25.26M | 1.50M | -56.73M | -20.40M | 41.62M | 47.01M | -666.00K | 17.28M | -12.21M | -17.15M | 3.55M | 5.49M |
| Free Cash Flow | 67.08M | 37.63M | 75.26M | 55.38M | 78.17M | 58.37M | 63.52M | 67.77M | 53.62M | 63.76M | 69.48M | 59.53M |
This table shows 12 quarterly periods of Prestige Consumer Healthcare's cash flow statement, from Q1 2027 back to Q2 2024, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PBH's reporting calendar. What is a cash flow statement?